Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan

British Journal of Surgery

Volumn 95, Issue 1, 2008, Pages 102-110

  Chen, J R ^a   Chiang, J M ^b,c   Changchien, C R ^b   Chen, J S ^b   Tang, R P ^b   Wang, J Y ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TAIWAN; AGED; COHORT ANALYSIS; COLON POLYP; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MISMATCH REPAIR; PREVALENCE; SECOND CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; COHORT STUDIES; COLONIC POLYPS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; PREVALENCE; TAIWAN;

EID: 38549167666     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5786     Document Type: Article

References (44)

1. Wheeler JMD, Bodmer WF, Mortensen NJM. DNA mismatch repair genes and colorectal cancer. Gut 2000; 47: 148-153.
2. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-1027.
3. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-218.
4. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
5. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
6. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758-1762.
7. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268.
8. Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000; 37: 641-645.
9. Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet 2004; 65: 308-316.
10. Gruber SB. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology 2006; 130: 577-587.
11. Lamberti C, Kruse R, Ruelfs C, Caspari R, Wang Y, Jungck M et al. Microsatellite instability - a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut 1999; 44: 839-843.
12. Terdiman JP, Gum JR Jr, Conrad PG, Miller GA, Weinberg V, Crawley SC et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 2001; 120: 21-30.
13. Cawkwell L, Gray S, Murgatroyd H, Sutherland F, Haine L, Longfellow M et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999; 45: 409-415.
14. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248-1255.
15. Lanza G, Gafa R, Maestri I, Santini A, Matteuzzi M, Cavazzini L. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 2002; 15: 741-749.
16. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-1048.
17. Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005; 29: 96-104.
18. Ward RL, Turner J, Williams R, Pekarsky B, Packham D, Velickovic M et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005; 207: 377-384.
19. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO et al. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 2005; 128: 1160-1171.
20. de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10: 972-980.
21. Department of Health Taiwan. Health and Vital Statistics, Taiwan Area, R.O.C. San Min Book Company: Taipei, 1997.
22. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000; 18: 2193-2200.
23. Percesepe A, Borghi F, Menigatti M, Losi L, Foroni M, Di Gregorio C et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 2001; 19: 3944-3950.
24. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001; 121: 830-838.
25. Katballe N, Christensen M, Wikman FP, Orntoft TF, Laurberg S. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002; 50: 43-51.
26. Chaves P, Cruz C, Lage P, Claro I, Cravo M, Leitao CN et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191: 355-360.
27. Christensen M, Katballe N, Wikman F, Primdahl H, Sorensen FB, Laurberg S et al. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 2002; 95: 2422-2430.
28. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352: 1851-1860.
29. Coggins RP, Cawkwell L, Bell SM, Crockford GP, Quirke P, Finan PJ et al. Association between family history and mismatch repair in colorectal cancer. Gut 2005; 54: 636-642.
30. Church J, McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded? Dis Colon Rectum 2000; 43: 1540-1544.
31. Katballe N, Juul S, Christensen M, Orntoft TF, Wikman FP, Laurberg S. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg 2001; 88: 1228-1233.
32. Muller A, Giuffre G, Edmonston TB, Mathiak M, Roggendorf B, Heinmoller E et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 2004; 6: 308-315.
33. Mangold E, Pagenstecher C, Friedl W, Fischer HP, Merkelbach-Bruse S, Ohlendorf M et al. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol 2005; 207: 385-395.
34. Kane MF, Loda M, Gaia GM, Lipman J, Mishra R, Goldman H et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-811.
35. Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK et al. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res 2004; 10: 481-490.
36. Bouzourene H, Taminelli L, Chaubert P, Monnerat C, Seelentag W, Sandmeier D et al. A cost-effective algorithm for hereditary nonpolyposis colorectal cancer detection. Am J Clin Pathol 2006; 125: 823-831.
37. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68: 118-127.
38. Bisgaard ML, Jager AC, Myrhoj T, Bernstein I, Nielsen FC. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation. Hum Mutat 2002; 20: 20-27.
39. Mueller-Koch Y, Vogelsang H, Kopp R, Lohse P, Keller G, Aust D et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54: 1733-1740.
40. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293: 1979-1985.
41. de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, Cats A, Menko FH, Griffioen G et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003; 52: 1752-1755.
42. Van Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B. Patterns of surgery in patients belonging to Amsterdam-positive families. Dis Colon Rectum 2003; 46: 617-620.
43. Vasen HF, de Vos Tot Nederveen Cappel WH. An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndrome. Gut 2005; 54: 1501-1502.
44. Olschwang S, Laurent-Puig P, Eisinger F, Millat B. An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndrome. Gut 2005; 54: 169.